Line Boulland

Author information from the last article

Section for Transplantation Immunology

Department of Immunology and Transfusion Medicine

Oslo University Hospital

Author contribution: analysis and interpretation of data, literature search, drafting and approval of the manuscript.

Line Boulland, PhD, MD, specialist in internal medicine, renal diseases and immunology and transfusion medicine. She is a senior consultant and head of the Section for Transplantation Immunology.

The author has completed the ICMJE form and declares no conflicts of interest.

Convalescent plasma from Norwegian blood donors to treat COVID-19

Lise Sofie Haug Nissen-Meyer,
Tine Torsvik Steinsvåg,
Mona Høysæter Fenstad,
Ingvild Hausberg Sørvoll,
Marte Hvalryg,
Thomas Larsen Titze,
Karin Magnussen,
Gunn Kristoffersen,
Kathrine Margrethe Neuman Johnsen,
Abid Hussain Llohn,
Brita Hermundstad,
Lilja Synnøve Høiback,
Morten Haugen,
Einar K. Kristoffersen,
Line Boulland,
Anne-Marte Bakken Kran,
Fridtjof Lund-Johansen,
John Torgils Vaage,
Øystein Flesland,
Tor Audun Hervig

03.08.2023: Convalescent plasma for the treatment of COVID-19 is a blood component from a donor who has recovered from COVID-19. Despite uncertainty about its efficacy, many countries, including Norway, initiated the collection and use of COVID-19 convalescent plasma. The set-up and background of the Norwegian...